Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$839,601
+$195,762 QoQ
Shares Held
700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
#3,294
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Burk Holdings LLC holds $1,124,967 across 12 Drug Manufacturers - General names. LLY ranks #1 (74.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
700 | $839,601 | |
| 2 | JNJ |
Johnson & Johnson
|
452 | $114,794 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
361 | $45,608 | |
| 4 | MRK |
Merck & Co., Inc.
|
304 | $39,064 | |
| 5 | ABBV |
AbbVie Inc.
|
119 | $29,945 | |
| 6 | AMGN |
Amgen Inc
|
31 | $11,225 | |
| 7 | PFE |
Pfizer Inc
|
454 | $10,932 | |
| 8 | NVS |
Novartis AG
|
64 | $10,030 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $839,601 | 700 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $643,839 | 700 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $679,197 | 632 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $444,066 | 582 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $453,686 | 582 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $480,679 | 582 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $449,304 | 582 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||